We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Mixed sites/palliation
Digital Poster
Clinical
Survival prediction using temporal muscle thickness measurements on cranial MRIs in patients with newly diagnosed brain metastases
Iglika MIHAYLOVA, Bulgaria
-22
Radiotherapy to Resection Cavities Following Brain Metastasis Surgery: Clinical Outcomes and Challenges
Christina Schröder, Switzerland
-293
Efficacy of Targeted Osmotic Lysis for Advanced Carcinomas
Dennis Paul, USA
-328
STEREOTACTIC BODY RADIOTHERAPY FOR PERITONEAL OR ABDOMINAL WALL OLIGOMETASTASES: PRELIMINARY RESULTS FROM A MONO-INSTITUTIONAL ANALYSIS
Francesco Cuccia, Italy
-343
Intraoperative Radiotherapy for Resectable Brain Metastases: Systematic Review, Meta-Analysis and Update from the Largest Single Center Experience
Julian Philipp Layer, Germany
-458
Stereotactic Body Radiation Therapy in the Management of Bone Metastases from Different Primary Sites
DANIELA MARIEL ANGEL SCHUTTE, Argentina
-480
Radiobiological dose and treatment duration influence pain relief and sensory outcomes in CyberKnife radiosurgery for trigeminal neuralgia
Evangelos Pantelis, Greece
-602
Palliative radiotherapy for bone metastases by dose-escalated IMRT versus conventional 3-D CRT using Mizumoto score for patient stratification
Nihal Thokchom, India
-800
Patient-Based Dosimetric and Outcome Analysis of Photon GRID Radiotherapy: Insights from a Large Institutional Experience
Kaidi Wang, USA
-974
Risk factors that may predict time to development of metastatic spinal cord compression in patients with metastatic castrate resistant prostate cancer
Alexander Batty, United Kingdom
-1124
Percutaneous Ablation and Cementoplasty combined with Adjuvant Radiotherapy in Patients with Painful Bone Metastases: A Retrospective Analysis
Cristina Gutiérrez Miguélez, Spain
-1150
Sleep, quality of life and fatigue in breast and lung cancer patients undergoing radiotherapy: A cross-sectional survey study
Atalay Balsak, Turkey
-1297
Comparative Validation of Prognostic Indices and the Combined Impact of Diagnostic and Treatment-Related Variables in Patients With Brain Metastases
Mehmet Halıcı, Turkey
-1302
Survival and fractionation in Metastatic Spinal Cord Compression
Sofie Lythcke-Elberling, Denmark
-1368
Preliminary Experience of HyperArc Stereotactic Radiotherapy for Resected Large Brain Metastases
Emmanuel Mesny, France
-1375
Safety and Efficacy of Spinal Re-Irradiation: Preliminary Results from the Multicentric RIMESPINE Trial
Donato Pezzulla, Italy
-1385
Effectiveness of palliative radiotherapy in nonagenarian patients with head and neck cancers.
Anna Bandurska-Luque, Poland
-1455
Early Changes in Quality of Life Following Cancer Diagnosis: A Prospective Comparative Study.
Fatjona Kraja, Albania
-1772
Feasibility of radiotherapy management in synchronous prostate and rectal cancer: institutional experience.
Laura María Álvarez González, Spain
-1794
efficacy and safety of single-fraction linac-based stereotactic radiosurgery for brainstem metastases: A UK institutional experience
Mohammad Emarah, United Kingdom
-1939
Identifying “Evaluable but Not Evaluated (EBNE)” Patients After Palliative Radiotherapy: A Real-World Gap in Follow-up
Hiroshi Tanaka, Japan
-1965
Hyper-radiosensitivity-guided sequencing radiotherapy in re-irradiation or radioresistant patients
Shao-Wei Chiang, Taiwan, Province of China
-2031
Single-isocenter non-coplanar stereotactic radiosurgery for brain metastasis in Hong Kong: long term outcomes and prognostic factors
Philip Yuguang Wu, China, Hong Kong Special Administrative Region
-2269
REIRRADIATION OF BRAIN METASTASES: EXPERIENCE OF A HIGH-VOLUME CENTER.
Miriam Torrisi, Italy
-2320
Multidisciplinary spinal cord compression committee as a tool to improve the selection of patients eligible for surgery. A single center experience.
MARC RUIZ DOMÍNGUEZ, Spain
-2413
Clinical outcome and toxicity of stereotactic radiotherapy in patients with brain metastases
Sindhu nagaraja, Germany
-2460
Characteristics of long-term survivors of brain metastases treated with radiation
Sergi Benavente, Spain
-2499
Applications in clinical practice of the Lattice Radiation Therapy: results and future possibilities
Davide Di Gennaro, Italy
-2801
Hippocampal dosimetry and implication for treatment planning in patients undergoing stereotactic radiosurgery for limited brain metastases.
Najmus Sahar Iqbal, United Kingdom
-2816
Association of initial response after stereotactic radiotherapy for symptomatic large brain metastases with neurological improvement and survival
Takayuki Sakurai, Japan
-2925
Current Practices of Hypofractionation in Proton Therapy: Results from a European Multi-Center Survey
Floriana Pansini, Italy
-3065
Encouraging Clinical Outcomes from the First 20 Patients Treated with a Helical Lattice-VMAT Approach Enhancing Low-Valley Dose Reduction
Santiago Velázquez Miranda, Spain
-3214
SBRT for hepatocellular carcinoma: survival outcomes and dose–response analysis
Victoria Alonso González, Spain
-3256
Hemostatic radiotherapy: what contribution does it make to the treatment of gastric tumors?
Nabila SELLAL, Morocco
-3312
Five-fraction spine stereotactic body radiation therapy: practice patterns and outcomes from a single institution
Ecem Yigit, Turkey
-3317
Reirradiation with Proton Therapy Using Hypofractionated Schedules:a Systematic Review of the Literature
Stefania Volpe, Italy
-3534
Simulation-free, same-day, palliative online adaptive radiotherapy: Clinical implementation of a phantom-based workflow, compressing days into hours
Monica Serban, Canada
-3569
Postoperative Radiotherapy for Extremity Bone Metastases: An Updated Systematic Review
Henry Wong, China, Hong Kong Special Administrative Region
-3602
Important issues from healthcare professional and patient perspectives regarding the quality of life in bone metastases
Shing Fung Lee, Singapore
-3639
Deep hyperthermia and radiotherapy: A promising palliative treatment option for recurrent and treatment-refractory bulky tumours
Moritz Neesen, Switzerland
-3728
Hospitalization patterns and risk factors associated with radiotherapy interruption in cancer patients: Experience from a radiation oncology ward.
Elena Gómez Duque, Spain
-3807
Long-term ophthalmologic outcomes after radiotherapy for choroidal metastases: a single-centre cohort study
Anna Lucas , Spain
-3956
LINACS: Living systematic review and meta-analysis of toxicity following combined treatment with novel systemic therapy and stereotactic radiotherapy
Esmee Lauren Looman, Switzerland
-4027
Radiotherapy in Patients Aged ?90 Years: Propensity-Matched Comparison With Those Aged 75–89
Yumi Kokubo, Japan
-4105
Optimizing palliative radiotherapy delivery: Insights from a Tunisian center audit
Mouna Ben Rejeb, Tunisia
-4138
Comparative effectiveness of SRS/SRT versus HA-WBRT for 5 to 15 brain metastases: a propensity score analysis
Wannit Witoonchart, Thailand
-4212
Re-irradiation of Bone Metastases: clinical and dosimetric insights from a large retrospective series.
Chiara Lorubbio, Italy
-4290
Stereotactic radiotherapy (SRT) for local retreatment of recurrent/progressive brain metastases after prior SRT: a monocentric feasibility experience
Elisa Dangelo, Italy
-4393
Feasibility and efficacy of re-irradiation with magnetic-resonance-image guided radiation therapy (MR- LINAC)
Fabian Allmendinger, Germany
-4482
Incidence and Predictive Factors of Radionecrosis After Hypofractionated Stereotactic Radiotherapy for Brain Metastases: A Retrospective Analysis
Luisa Díaz, Spain
-4564
Geriatric Assessment in Radiation Oncology Outpatient Department: Feasibility and Clinical Relevance
Vaishali Kataria, India
-4585
Outcomes of the Quad Shot palliative radiotherapy regimen: a retrospective analysis
Bartosz Sobocki, Poland
-4636
Palliative radiotherapy in ECOG PS 3-4: large-cohort outcomes with ultra-short fractionation
Per Munck af Rosenschold, Sweden
-4642
Acute toxicity of hypofractionated Proton therapy: report from the European Institute of Oncology
Stefania Volpe, Italy
-4693
Early Clinical Outcome of Spatially Fractionated Stereotactic Body Radiation Therapy (Lattice) in the Treatment of Bulky, Advanced Tumors
Natalie Sean Man Wong, China, Hong Kong Special Administrative Region
-4707
Real world quality-of-life outcomes after modulated electro-hyperthermia across tumour types.
Claudia F. Pedrero, Spain
-4713
Combining Deep Hyperthermia with Radiotherapy: Feasibility, Safety, and Clinical Outcomes in a Retrospective Patient Cohort.
Letizia Deantonio, Switzerland
-4751
Volumetric response following serial stereotactic radiosurgery for multiple metachronous brain metastases.
Susanne Rogers, Switzerland
-4755
Applicability of MDA versus RECIST criteria in the evaluation of response to stereotactic body radiation therapy in rib metastase
Chiara Mattioli, Italy
-4783
Single vs Fractionated Stereotactic Radiotherapy for Brain Metastases: A comparative Study
Lucrezia Toppi, Italy
-4974
PD-L1 and GPA Accuracy in Lung Cancer Brain Metastases Treated with WBRT
Maria Cerrolaza, Spain
-5018
Understanding SRS for brain metastasis: Stratification of patients who benefit from SRS/SRT to multiple metastases and multiple courses of treatment
Amy Colori, United Kingdom
-5071
Determinants of Graded Prognostic Assessment predictive accuracy in lung and breast cancer brain metastases treated with whole-brain radiotherapy
Maria Cerrolaza, Spain
-5133
Repeat stereotactic radiosurgery for locally recurrent brain metastases: outcomes and dosimetric predictors of radionecrosis
Mehmet Ufuk Abacioglu, Turkey
-5135
Partially ablative body radiotherapy (PABR) for large unresectable tumors: a single institution experience
Francy Elisa Salcedo arias, Spain
-5149
Whole-brain exposure and treatment efficiency in C-arm single-isocenter stereotactic radiosurgery of brain metastases
Maximilian Grohmann, Germany
-281